Using Cost-Effectiveness Evidence to Inform Decisions as to which Health Services to Provide

被引:13
作者
Cairns, John [1 ]
机构
[1] London Sch Hyg & Trop Med, Hlth Serv Res & Policy, London, England
关键词
cost-effectiveness threshold; decision making; drug adoption; health technology assessment; QALYs;
D O I
10.1080/23288604.2015.1124172
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This article focuses on three challenges concerning the use of cost-effectiveness thresholds to inform decision making regarding which services a third-party payer will fund. First, how is the appropriate cost-effectiveness threshold or threshold range to be determined or, indeed, should there be a single threshold or multiple thresholds? Second, how can the valuation of health benefits be refined to better capture the value of treatments to patients and to the economy as a whole? Third, how is the tension between cost-effectiveness and the affordability and sustainability of health services to be managed? It concludes that whatever other factors are considered in addition to cost-effectiveness, and whether the decision-making process is more or less deliberative, cost-effectiveness thresholds are important. Though there is a range of sources for identifying appropriate thresholds, using the opportunity cost in terms of the health benefits from displaced activities will minimize the problem of cost-effective interventions not being affordable and will facilitate the efficient use of scarce resources. Finally, although experience using weighted quality-adjusted life years (QALYs) is currently very limited, it is likely to be an important area in the future.
引用
收藏
页码:32 / 38
页数:7
相关论文
共 20 条
[1]  
[Anonymous], 2013, GUID METH TECHN APPR
[2]  
Barnsley P, 2013, 81 OFF HLTH EC
[3]  
Basu A, 2013, EXPERT REV PHARM OUT, V13, P163, DOI [10.1586/ERP.13.8, 10.1586/erp.13.8]
[4]   Evidence and values: paying for end-of-life drugs in the British NHS [J].
Chalkidou, Kalipso .
HEALTH ECONOMICS POLICY AND LAW, 2012, 7 (04) :393-409
[5]   Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold [J].
Claxton, Karl ;
Martin, Steve ;
Soares, Marta ;
Rice, Nigel ;
Spackman, Eldon ;
Hinde, Sebastian ;
Devlin, Nancy ;
Smith, Peter C. ;
Sculpher, Mark .
HEALTH TECHNOLOGY ASSESSMENT, 2015, 19 (14) :1-+
[6]  
Culyer Anthony, 2007, J Health Serv Res Policy, V12, P56, DOI 10.1258/135581907779497567
[7]   THE INFLUENCE OF COST-EFFECTIVENESS AND OTHER FACTORS ON NICE DECISIONS [J].
Dakin, Helen ;
Devlin, Nancy ;
Feng, Yan ;
Rice, Nigel ;
O'Neill, Phill ;
Parkin, David .
HEALTH ECONOMICS, 2015, 24 (10) :1256-1271
[8]  
Departementenes sikkerhets-og serviceorganisasjon, 2014, AP RETTF PRIOR HELS, P1
[9]  
Department of Health, 2013, METH EST WID SOC BEN
[10]   Priority-Setting Institutions in Health Recommendations from a Center for Global Development Working Group [J].
Glassman, Amanda ;
Chalkidou, Kalipso ;
Giedion, Ursula ;
Teerawattananon, Yot ;
Tunis, Sean ;
Bump, Jesse B. ;
Pichon-Riviere, Andres .
GLOBAL HEART, 2012, 7 (01) :13-34